The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice

Prenatal Diagnosis

Volumn 30, Issue 7, 2010, Pages 644-652

  Benacerraf, Beryl R ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Diagnostic Ultrasound Associates   (United States)

Author keywords

Down syndrome; Echogenic intracardiac focus; Fetal imaging; Fetal ultrasound; Nuchal fold; Screening; Ultrasound markers

Indexed keywords

CLINICAL PRACTICE; DISEASE MARKER; DOWN SYNDROME; ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; NASAL BONE; OBSTETRIC CARE; OSSIFICATION; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; BLOOD; FEMALE; FETUS; FETUS ECHOGRAPHY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PROCEDURES;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; FETUS; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, SECOND; ULTRASONOGRAPHY, PRENATAL;

EID: 77954107966     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2531     Document Type: Review

References (90)

1. Aagaard-Tillery KM, Malone FD, Nyberg DA, et al. 2009. Role of second-trimester genetic sonography after Down syndrome screening. Am J Obstet Gynecol 114: 1189-1196.
2. Adams MM, Erickson JD, Layde PM, Oakley GP. 1981. Down's syndrome: recent trends in the United States. JAMA 246: 758-760. (Pubitemid 11044327)
3. Anderson N, Jyoti R. 2003. Relationship of isolated fetal intracardiac echogenic focus to trisomy 21 at the mid-trimester sonogram in women younger than 35 years. Ultrasound Obstet Gynecol 21: 354-358.
4. Bahado-Singh RO, Oz U, Hsu CD, Deren O, Copel JA, Mahoney MJ. 2001. Ratio of nuchal thickness to humerus length for Down syndrome detection. Am J Obstet Gynecol 184: 1284-1288.
5. Bahado-Singh RO, Wyse L, Dorr MA, et al. 1992. Fetuses with Down syndrome have disproportionately shortened frontal lobe dimensions on ultrasonographic examination. Am J Obstet Gynecol 167: 1009-1014.
6. Benacerraf BR, Barss VA, Laboda LA. 1985. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol 151: 1078-1079.
7. Benacerraf BR, Cnaan A, Gelman R, et al. 1989. Can sonographers reliably identify anatomy features associated with Down syndrome?. Radiology 173: 377-380. (Pubitemid 19264588)
8. Benacerraf BR, Frigoletto FD Jr 1987. Soft tissue nuchal fold in the second trimester fetus: standards for normal measurements compared to the fetus with Down syndrome. Am J Obstet Gynecol 157: 1146-1149.
9. Benacerraf BR, Frigoletto FD, Cramer DW Jr. 1987a. Down syndrome: sonographic sign for diagnosis in the second-trimester fetus. Radiology 163: 811-813.
10. Benacerraf BR, Gelman R, Frigoletto FD Jr. 1987b. Sonographic identification of second trimester fetuses with Down syndrome. N Engl J Med 317: 1371-1376.
11. Benacerraf BR, Harlow B, Frigoletto FD Jr. 1990. Hypoplasia of the middle phalanx of the fifth digit, a feature of the second trimester fetus with Down syndrome. J Ultrasound Med 9: 389-394. (Pubitemid 20303779)
12. Benacerraf BR, Laboda LA, Frigoletto FD Jr. 1992a. Thickened nuchal fold in fetuses not at risk for aneuploidy. Radiology 184: 239-242.
13. Benacerraf BR, Mandell J, Estroff JA, et al. 1990. Fetal pyelectasis, a possible association with Down syndrome. Obstet Gynecol 76: 58-60. (Pubitemid 20205219)
14. Benacerraf BR, Nadel A, Bromley B. 1994. Identification of second trimester fetuses with autosomal trisomy by use of a sonographic scoring index. Radiology 193: 135-140. (Pubitemid 24298014)
15. Benacerraf BR, Neuberg D, Frigoletto FD Jr. 1991. Humeral shortening in second-trimester fetuses with Down syndrome. Obstet Gynecol 77: 223-227.
16. Benacerraf BR, Neuberg D, Bromley B, et al. 1992b. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med 11: 449-458. (Pubitemid 23047014)
17. Benoit B, Chaoui R. 2005. Three-dimensional ultrasound with maximal mode rendering: a novel technique for the diagnosis of bilateral or unilateral absence or hypoplasia of nasal bones in second-trimester screening for Down syndrome. Ultrasound Obstet Gynecol 25: 19-24.
18. Bethune M. 2008. Time to reconsider our approach to echogenic intracardiac focus and choroid plexus cysts Australian and New Zealand. Journal of Obstetrics and Gynaecology 48: 137-141.
19. Boyd PA, Chamberlain P, Hicks NR. 1998. Six year experience of prenatal diagnosis in an unselected population in Oxford, UK. Lancet 352: 1577-1581.
20. Bradley KE, Santulli TS, Gregory KD, et al. 2005. An isolated intracardiac echogenic focus as a marker for aneuploidy. Am J Obstet Gynecol 192: 2021-2026.
21. Brizot ML, Snijders RJM, Bersinger NA, et al. 1994. Maternal serum pregnancy associated placental protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy. Obstet Gynecol 84: 918-922.
22. Brizot ML, Snijders RJM, Butler J, et al. 1995. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy. Br J Obstet Gynaecol 102: 127-132.
23. Bromley B, Doubilet P, Frigoletto FD Jr, et al. 1994. Is fetal hyperechoic bowel on second trimester sonogram an indication for amniocentesis? Obstet Gynecol 83: 647-651.
24. Bromley B, Frigoletto FD, Harlow BL, Benacerraf BR, RADIUS Study Group. 1993. Biometric measurements in fetuses of different races and gender. Ultrasound Obstet Gynecol; 3: 395-402.
25. Bromley B, Lieberman E, Laboda LA, et al. 1995. Echogenic intracardiac focus, a sonographic sign for Down Syndrome?. Obstet Gynecol 86: 998-1001.
26. Bromley B, Lieberman E, Benacerraf B. 1997. The incorporation of maternal age into the sonographic scoring index for the detection at 14-20 weeks of fetuses with Down's syndrome. Ultrasound Obstet Gynecol 10: 321-324.
27. Bromley B, Lieberman E, Benacerraf BR. 1996. Choroid plexus cysts: not associated with Down syndrome. Ultrasound Obstet Gynecol 8: 232-235. (Pubitemid 126720524)
28. Bromley B, Lieberman E, Shipp T, et al. 2002a. Fetal nasal bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med 21: 1387-1394. (Pubitemid 35425092)
29. Bromley B, Lieberman E, Shipp TD, Benacerraf BR. 2002b. The genetic sonogram, a method for risk assessment for Down syndrome in the mid trimester. Journal Ultrasound Med 21: 1087-1096.
30. Cicero S, Curcio P, Papageorghiou A, et al. 2001. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 358: 1665-1667.
31. Cicero S, Sonek J, McKenna D, et al. 2003. Nasal bone hypoplasia in fetuses with Trisomy 21 at 15-22 weeks' gestation. Ultrasound Obstet Gynecol 21: 15-18. (Pubitemid 36831232)
32. Coco C, Jeanty P, Jeanty C. 2004. An isolated echogenic heart focus is not an indication for amniocentesis in 12672 unselected patients. J Ultrasound Med 23: 489-496.
33. Corteville JE, Dicke JM, Crane JP. 1992. Fetal pyelectasis and Down syndrome, is genetic amniocentesis warranted?. Obstet Gynecol 79: 770-772.
34. Cusick W, Provenzano J, Sullivan C, et al. 2004. Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks' gestation: a prospective study. J Ultrasound Med 23: 1327-1333.
35. DeVore GR, Alfi O. 1997. The use of color Doppler ultrasound to identify fetuses at increase risk for trisomy 21: an alternative for high-risk patients who decline genetic amniocentesis. Obstet Gynecol 90: 187-194.
36. DeVore GR, Romero R. 2003. Genetic sonography: an option for women of advanced maternal age with negative triple-marker maternal serum screening results. J Ultrasound Med 22: 1191-1199.
37. Dicke JM, Crane JP. 1992. Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management. Obstet Gynecol 80: 778-782.
38. Donnenfeld AE, Meister D, Allison J, Brennan K, Ludomirsky A, Rightmire D. 1995. Interobserver variability of sonographically determined second-trimester nuchal skinfold thickness measurements. Ultrasound Obstet Gynecol 5: 119-122.
39. Doubilet PM, Copel JA, Benson CB, et al. 2004. Choroidplexus cysts and echogenic intracardiac focus in women at low risk for chromosomal anomalies: the obligation to inform the mother. J Ultrasound Med 23: 883-888.
40. Egan JF, Benn P, Borgida AF, et al. 2000. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 96: 979-985.
41. Filly RA, Benacerraf BR, Nyberg DA, Hobbins JC. 2004. Choroid plexus cysts and echogenic intracardiac focus in women at low risk for chromosomal anomalies. J Ultrasound Med 23: 447-449.
42. FitzSimmons J, Droste S, Shepard TH, et al. 1989. Long-bone growth in fetuses with Down syndrome. Am J Obstet Gynecol 161: 1174-1177.
43. Gill P, Vanhook J, Fitzsimmons J, et al. 1994. Fetal ear measurements in the prenatal detection of trisomy 21. Prenat Diagn 14: 739-743.
44. Gupta JK, Cave M, Lilford RF, et al. 1995. Clinical significance of fetal choroid plexus cysts. Lancet 346: 724-729.
45. Hobbins JC, Lezotte DC, Persutte WH, et al. 2003. An 8-center study to evaluate the utility of midterm genetic sonograms among highrisk pregnancies. J Ultrasound Med 22: 33-38.
46. Kirwan D, the NHS Fetal Anomaly Screening Programme (NHS FASP). NHS Fetal Anomaly Screening Programme 18+0 to 20+6 Weeks Fetal Anomaly Scan. National Standards and Guidance for England. 2010. p 71. www.fetalanomaly.screening.nhs. uk.
47. Krantz DA, Hallahan TW, Macri VJ, et al. 2007. Genetic sonography after first-trimester Down syndrome screening. Ultrasound Obstet Gynecol 29: 666-670.
48. Lehman CD, Nyberg DA, Winter III TC, et al. 1995. Trisomy 13 syndrome: prenatal US findings in a review of 33 cases. Radiology 194: 217-222.
49. Lettieri L, Rodis JF, Vintzileos AM, et al. 1993. Ear length in second trimester aneuploid fetuses. Obstet Gynecol 81: 57-60. (Pubitemid 23041703)
50. Lockwood C, Benacerraf B, Krinsky A, et al. 1987. A sonographic screening method for Down syndrome. Am J Obstet Gynecol 157: 803-808.
51. Malone FD, Canick JA, Nyberg DA, et al. 2005. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353: 2001-2011.
52. Malone FD, Nyberg DA, Vidaver J, et al. 2004. First and second trimester evaluation of risk (FASTER) trial: the role of second trimester genetic sonography. Am J Obstet Gynecol 191: S3-S3.
53. Maymon R, Zimerman AL, Weinraub Z, Herman A, Cuckle H. 2008. Correlation between nuchal translucency and nuchal skinfold measurements in Down syndrome and unaffected fetuses. Ultrasound Obstet Gynecol 32: 501-505.
54. Nicolaides KH, Azar G, Byrne D, et al. 1992. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304: 867-869.
55. Nyberg DA, Luthy DA, Resta RG, et al. 1998. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 12: 8-14.
56. Nyberg DA, Luthy DA, Cheng EY, et al. 1995. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers. Am J Obstet Gynecol 173: 1030-1035.
57. Nyberg DA, Resta RG, Luthy DA, et al. 1990. Prenatal sonographic findings of Down syndrome: a review of 94 cases. Obstet Gynecol 76: 370-377.
58. Nyberg DA, Resta RG, Mahony BS, et al. 1993. Fetal hyperechogenic bowel and Down's syndrome. Ultrasound Obstet Gynecol 3: 330-333.
59. Nyberg DA, Souter VL, El-Bastawissi A, et al. 2001. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med 10: 1053-1063.
60. Odibo AO, Sehdev HM, Dunn L, et al. 2004. The association between fetal nasal bone hypoplasia and aneuploidy. Obstet Gynecol 104: 1229-1233.
61. Odibo AO, Sehdev HM, Sproat L, et al. 2006. Evaluating the efficiency of using second-trimester nasal bone hypoplasia as a single or a combined marker for fetal aneuploidy. J Ultrasound Med 25: 437-434.
62. Pandya PP, Snijders RJM, Johnson SJ, et al. 1995. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks gestation. Br J Obstet Gynaecol 102: 957-962.
63. Pinette MG, Egan JFX, Wax JR, et al. 2003. Combined sonographic and biochemical markers for Down syndrome screening. J Ultrasound Med 22: 1185-1190.
64. Roberts DJ, Genest D. 1992. Cardiac histologic pathology characteristic of trisomies 13 and 21. Human Pathology 23: 1130-1140.
65. Rosen DJD, Kedar I, Amiel A, et al. 2002. A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%. Prenat Diagn 22: 59-63.
66. Rotmensch S, Liberati M, Bronshtein M, et al. 1997. Prenatal sonographic findings in 187 fetuses with Down syndrome. Prenat Diagn 17: 1001-1009.
67. Rozenberg P, Bussieres L, Chevret S, et al. 2006. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol 195: 1379-1387.
68. Schluter PJ, Pritchard G. 2005. Mid trimester sonographic findings for the prediction of Down syndrome in a sonographically screened population. Am J Obstet Gynecol 192: 10-16.
69. Scioscia AL, Pretorius DH, Budorick NE, et al. 1992. Second-trimester hyperechoic bowel and chromosomal abnormalities. Am J Obstet Gynecol 167: 889-894.
70. Seelaus C, Wicklund C, Yates C, Dungan J. 2009. Practice patterns of maternal-fetal medicine specialists in counseling patients with isolated soft markers for aneuploidy. Am J Obstet Gyncol 201: S134-S135.
71. Sepulveda W, Sebire NJ. 2000. Fetal Echogenic bowel: a complex scenario. Ultrasound Obstet Gynecol 16: 510-514.
72. Shimizu T, Salvador L, Hughes-Benzie R, et al. 1997. The role of reduced ear size in the prenatal detection of chromosomal abnormalities. Prenat Diagn 17: 545-549.
73. Shipp TD, Bromley B, Lieberman E, et al. 1997. The iliac angle as a sonographic marker for Down syndrome in second trimester fetuses. Obstet Gynecol 89: 446-450.
74. Shipp TD, Bromley B, Lieberman E, et al. 2000. The frequency of the detection of fetal echogenic intracardiac foci with respect to maternal race. Ultrasound Obstet Gynecol 15: 460-462.
75. Shipp TD, Bromley B, Mascola M, et al. 2001. Variation in fetal femur length with respect to maternal race. J Ultrasound Med 20: 141-144. (Pubitemid 32105754)
76. Smith-Bindman R, Hosmer W, Feldstein V, et al. 2001. Second-trimester ultrasound to detect fetuses with Down syndrome a metaanalysis. JAMA 285: 1044-1055.
77. Snijders RJ, Noble P, Sebire N, et al. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchaltranslucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 352: 343-346.
78. Sonek J, Nicolaides K. 2002. Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am J Obstet Gynecol 186: 139-141.
79. Souter VL, Nyberg DA, Benn PA, et al. 2004. Correlation of second-trimester sonographic and biochemical markers. J Ultrasound Med 23: 505-511.
80. Thilaganathan B, Olawaiye A, Sairam S, Harrington K. 1999. Isolated fetal echogenic intracardiac foci or golf balls: is karyotyping for Down's syndrome indicated?. Br J Obstet Gynaecol 106: 1294-1297.
81. Vintzileos A, Walters C, Yeo L. 2003. Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high-risk population. Obstet Gynecol. 101: 905-908.
82. Vintzileos AM, Campbell WA, Rodis JF, et al. 1996. The use of second trimester genetic sonogram in building clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol 87: 948-952.
83. Vintzileos AM, Guzman ER, Smulian JC, et al. 1997. Choice of second-trimester genetic sonogram for detection of trisomy 21. Obstet Gynecol 90: 187-190.
84. Vintzileos AM, Guzman ER, Smulian JC, et al. 2002a. Down syndrome risk estimation after normal genetic sonography. Am J Obstet Gynecol 187: 1226-1229.
85. Vintzileos AM, Guzman ER, Smulian JC, et al. 2002b. Second-trimester genetic sonography in patients with advanced maternal age and normal triple screen. Obstet Gynecol 99: 993-995.
86. Wald NJ, Kennard A, Hackshaw A, et al. 1997. Antenatal screening for Down's syndrome. J Med Screen 4: 181-246.
87. Wald NJ, Kennard A, Hackshaw AK. 1995. First trimester serum screening for Down's syndrome. Prenat Diagn 15: 1227-1240.
88. Wald NJ, Watt HC, Hackshaw AK. 1999. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
89. Winn VD, Sonson J, Filly RA. 2003. Echogenic intracardiac focus: potential for misdiagnosis. J Ultrasound Med 22: 1207-1214. (Pubitemid 37356552)
90. Winter TC, Anderson AM, Cheng EY, et al. 2000. Echogenic intracardiac focus in 2nd-trimester fetuses with Trisomy 21: usefulness as a US marker. Radiology 216: 450-467.